Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results

Intellia Therapeutics (NTLA) Misses Q4 EPS by 1c, Revenues Beat

February 27, 2020 7:37 AM EST

Intellia Therapeutics (NASDAQ: NTLA) reported Q4 EPS of ($0.57), $0.01 worse than the analyst estimate of ($0.56). Revenue for the quarter came in at $10.94 million versus the consensus estimate of $9.94 million.

In 2019, we advanced our full-spectrum strategy, guiding both our in vivo and ex vivo lead... More